InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,487.03
(
0.25%
)
US TECH 100
19,430.40
(
0.14%
)
Dow Jones
38,834.86
(
0.15%
)
Brent Oil
84.64
(
-0.18%
)
Bitcoin
65,103.38
(
-0.06%
)
Post# of 699501
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

flipper44

Send PM Follow Ignore
Followers 276
Posts 32697
Boards Moderated 0
Alias Born 11/14/2013

flipper44

Member Level

Re: None

Tuesday, 06/14/2016 12:29:15 AM

Tuesday, June 14, 2016 12:29:15 AM

Post# of 699501
Correct me if I'm wrong, but I do not think there is another similar phase III immunotherapy dendritic and/or peptide cancer vaccine trial due to reach final results prior to DCVax-L's phase III trial.

1. Celldex's Rindopepimut is no longer viable.
2. IMUC's phase III trial final primary results are a couple years out.
3. Agenus' Prophage results aren't due for years.
4. Argos phase III trial results for RCC are not due until February 2017.


Does anyone know of any potential pivotal intervening trial results we should be paying attention to prior to the end of this year?

Respect Risk. Conduct Your Own Due Diligence. Manage your assets wisely. Diversify.

Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News
InvestorsHub NewsWire

North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM

VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM

Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM

Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM

ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM

Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM

Start posting your company's news
Only $200 per official company press release!